stock
None
NASDAQ:RGEN
246.27
+2.97 (+1.22%)
As of 2022-08-05 Close (EST)
52 Week Rng -
Market Cap -
Avg Volume -
1M Volatility -
Short Ratio -
P/E Ratio (TTM) -
P/E Ratio (Fwd) -
P/B Ratio -
Div & Yield -
BUY
19
Filled
ACTION
TICKER
SHARES
STATUS
BUY
17
Filled
ACTION
TICKER
SHARES
STATUS
BUY
40
Filled
ACTION
TICKER
SHARES
STATUS
BUY
25
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
200
Filled
ACTION
TICKER
SHARES
STATUS
BUY
6
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
70
Filled
ACTION
TICKER
SHARES
STATUS
BUY
90
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
11
Filled
ACTION
TICKER
SHARES
STATUS
SELL
364
Filled
ACTION
TICKER
SHARES
STATUS

mav9 OLD|Aalto Investment Management Game (Spring 2020) Mar 2020

Automatic trade executed by Stockfuse to ensure margin compliance.

[SELL]
333
Filled
ACTION
TICKER
SHARES
STATUS
SELL
2
Filled
ACTION
TICKER
SHARES
STATUS

slowmo73 Stockfuse Continuum (US) Dec 2019

Automatic trade executed by Stockfuse to ensure margin compliance.

SELL
60
Filled
ACTION
TICKER
SHARES
STATUS
BUY
1,500
×
ACTION
TICKER
SHARES
STATUS
[BUY]
20
Filled
ACTION
TICKER
SHARES
STATUS
[SELL]
24
Filled
ACTION
TICKER
SHARES
STATUS
BUY
360
Filled
ACTION
TICKER
SHARES
STATUS
SELL
100
Queued
ACTION
TICKER
SHARES
STATUS
BUY
100
Filled
ACTION
TICKER
SHARES
STATUS
BUY
4,061
Filled
ACTION
TICKER
SHARES
STATUS

EBJO OLD|Aalto Investment Management Game (Spring 2019) Jan 2019

Bioprocessing company that develops, produces and commercializes innovative biologic drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide.

Market cap: 2,4B USD P/E: 107,11 Consensus recommendation: Strong buy Revenue: 141,24 million (2017, +35,1 %)

Company is assessed positively by analysts and has a solid “buy” recommendation. They operate in a growing market segment in which they have good potential to create value for investors.

more
AAPL FB NFLX MSFT TSLA
Market data provided by Xignite, BATS BZX Real-Time Price, and SIX Financial Information.